$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000166607121000082 Filed on May 04, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2020 Q1
Revenue	$58.85M	$53.23M	$45.51M
YoY Change	108.54%	16.97%	26.46%
Cost Of Revenue	$29.22M	$29.77M	$26.14M
YoY Change	73.84%	13.89%	37.58%
Gross Profit	$29.63M	$23.46M	$19.37M
YoY Change	159.68%	21.12%	14.08%
Gross Profit Margin	50.35%	44.07%	42.56%
Selling, General & Admin	$33.95M	$25.38M	$21.71M
YoY Change	53.35%	16.88%	32.9%
% of Gross Profit	114.58%	108.17%	112.09%
Research & Development	$8.934M	$6.218M	$3.851M
YoY Change	125.26%	61.46%	30.94%
% of Gross Profit	30.15%	26.5%	19.88%
Depreciation & Amortization	$8.828M	$3.065M	$2.349M
YoY Change	469.55%	30.48%	144.43%
% of Gross Profit	29.79%	13.06%	12.13%
Operating Expenses	$42.89M	$31.60M	$25.56M
YoY Change	64.28%	23.6%	32.6%
Operating Profit	-$44.23M	-$22.17M	-$11.93M
YoY Change	124.08%	85.84%	83.49%
Interest Expense	-$3.078M	-$3.050M	-$1.600M
YoY Change	15290.0%	90.63%	433.33%
% of Operating Profit
Other Income/Expense, Net	-$3.078M	-$2.726M	-$1.602M
YoY Change	15290.0%	70.16%	-956.68%
Pretax Income	-$47.31M	-$24.90M	-$13.53M
YoY Change	139.43%	83.98%	114.3%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$47.31M	-$24.90M	-$13.53M
YoY Change	139.43%	83.98%	114.3%
Net Earnings / Revenue	-80.38%	-46.77%	-29.73%
Basic Earnings Per Share		-$0.85
Diluted Earnings Per Share	-$1.43	-$0.85	-$506.2K
COMMON SHARES
Basic Shares Outstanding	32.88M shares	29.31M shares	26.70M shares
Diluted Shares Outstanding	32.98M shares	29.31M shares

Balance Sheet

Concept	2021 Q2	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$250.6M	$613.5M	$102.2M
YoY Change	154.68%	500.29%	180.77%
Cash & Equivalents	$250.6M	$613.5M	$102.2M
Short-Term Investments
Other Short-Term Assets	$8.243M	$7.800M	$6.100M
YoY Change	26.82%	27.87%	-75.89%
Inventory
Prepaid Expenses
Receivables	$73.47M	$75.33M	$57.67M
Other Receivables	$6.142M	$5.911M	$4.066M
Total Short-Term Assets	$338.5M	$702.6M	$170.0M
YoY Change	131.18%	313.18%	44.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.10M	$14.12M	$13.09M
YoY Change	0.86%	7.89%	15.28%
Goodwill	$718.5M	$203.2M
YoY Change
Intangibles	$137.2M	$78.98M	$404.0K
YoY Change	33606.39%	19449.75%	10.08%
Long-Term Investments
YoY Change
Other Assets	$2.617M	$2.681M	$1.962M
YoY Change	53.85%	36.65%	43.32%
Total Long-Term Assets	$894.4M	$320.5M	$36.04M
YoY Change	2341.41%	789.28%	23.54%
TOTAL ASSETS
Total Short-Term Assets	$338.5M	$702.6M	$170.0M
Total Long-Term Assets	$894.4M	$320.5M	$36.04M
Total Assets	$1.233B	$1.023B	$206.1M
YoY Change	573.55%	396.43%	40.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.217M	$3.249M	$1.146M
YoY Change	343.25%	183.51%	-39.56%
Accrued Expenses	$8.207M	$8.714M	$3.003M
YoY Change	150.98%	190.18%	-19.77%
Deferred Revenue	$2.777M	$259.0K	$603.0K
YoY Change	186.58%	-57.05%	5.05%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$23.00K	$7.000K	$24.00K
YoY Change	-4.17%	-70.83%	9.09%
Total Short-Term Liabilities	$263.0M	$92.04M	$58.41M
YoY Change	519.34%	57.58%	17.86%
LONG-TERM LIABILITIES
Long-Term Debt	$179.2M	$176.5M	$7.000K
YoY Change		2521328.57%	-99.99%
Other Long-Term Liabilities	$679.0K	$679.0K	$9.300M
YoY Change	-93.28%	-92.7%
Total Long-Term Liabilities	$679.0K	$679.0K	$7.000K
YoY Change		9600.0%	-99.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$263.0M	$92.04M	$58.41M
Total Long-Term Liabilities	$679.0K	$679.0K	$7.000K
Total Liabilities	$518.5M	$278.1M	$67.72M
YoY Change	886.18%	310.73%	-54.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$466.3M	-$418.9M	-$352.2M
YoY Change	25.36%	18.96%	7.43%
Common Stock	$1.181B	$1.164B	$487.9M
YoY Change	136.42%	138.64%	30.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$714.4M	$744.9M	$138.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.233B	$1.023B	$206.1M
YoY Change	573.55%	396.43%	40.7%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$47.31M	-$24.90M	-$13.53M
YoY Change	139.43%	83.98%	114.3%
Depreciation, Depletion And Amortization	$8.828M	$3.065M	$2.349M
YoY Change	469.55%	30.48%	144.43%
Cash From Operating Activities	-$14.98M	-$12.53M	-$3.406M
YoY Change	254.14%	267.94%	129.67%
INVESTING ACTIVITIES
Capital Expenditures	-$2.949M	$1.377M	$492.0K
YoY Change	51.23%	179.88%	-67.02%
Acquisitions	$494.1M	$148.6M	$0.00
YoY Change
Other Investing Activities	-$345.5M	-$148.6M
YoY Change
Cash From Investing Activities	-$348.5M	-$152.0M	-$1.437M
YoY Change	17769.23%	10474.95%	-27.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$484.7M	$3.145M
YoY Change		15312.18%	1717.92%
Debt Paid & Issued, Net		$6.000K	$6.000K
YoY Change		0.0%	20.0%
Cash From Financing Activities	733.0K	$484.7M	$3.139M
YoY Change	-67.71%	15340.11%	1837.65%
NET CHANGE
Cash From Operating Activities	-14.98M	-$12.53M	-$3.406M
Cash From Investing Activities	-348.5M	-$152.0M	-$1.437M
Cash From Financing Activities	733.0K	$484.7M	$3.139M
Net Change In Cash	-362.7M	$320.3M	-$2.292M
YoY Change	9176.14%	-14075.13%	-27.97%
FREE CASH FLOW
Cash From Operating Activities	-$14.98M	-$12.53M	-$3.406M
Capital Expenditures	-$2.949M	$1.377M	$492.0K
Free Cash Flow	-$12.03M	-$13.91M	-$3.898M
YoY Change	427.68%	256.82%	31.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	cdlx	Debt Instrument Required Compliance Period Period After Exercise Of Conversion Right DebtInstrumentRequiredCompliancePeriodPeriodAfterExerciseOfConversionRight	P3D
CY2021Q1	cdlx	Debt Instrument Required Compliance Period Period After Fundamental Change DebtInstrumentRequiredCompliancePeriodPeriodAfterFundamentalChange	P1D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-38386
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2021Q1	dei	City Area Code CityAreaCode	(888)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	792-5802
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2021Q1	dei	Trading Symbol TradingSymbol	CDLX
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32876077	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293239000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	613548000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	110000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	111000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81249000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75334000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5306000	USD
CY2021Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5911000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5687000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7669000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	385591000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	702573000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13865000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14118000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10764000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10810000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	447000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78981000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021Q1	us-gaap	Goodwill Goodwill	203181000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6299000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7788000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3785000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	2903000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1786000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2681000	USD
CY2020Q4	us-gaap	Assets Assets	422537000	USD
CY2021Q1	us-gaap	Assets Assets	1023035000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1363000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3249000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7582000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8334000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5502000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8714000	USD
CY2020Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	37457000	USD
CY2021Q1	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	30708000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	265345000	USD
CY2020Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	24290000	USD
CY2021Q1	cdlx	Customer Incentive Liability CustomerIncentiveLiability	35318000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	349000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	259000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4718000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5448000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	81274000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	92037000	USD
CY2020Q4	us-gaap	Senior Notes SeniorNotes	174011000	USD
CY2021Q1	us-gaap	Senior Notes SeniorNotes	176540000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9381000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8887000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	679000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	679000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	278143000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	551429000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1164320000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-192000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-488000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-394053000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-418948000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	744892000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	422537000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1023035000	USD
CY2020Q1	us-gaap	Revenues Revenues	45509000	USD
CY2021Q1	us-gaap	Revenues Revenues	53230000	USD
CY2020Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	26138000	USD
CY2021Q1	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	29771000	USD
CY2020Q1	cdlx	Delivery Costs DeliveryCosts	3406000	USD
CY2021Q1	cdlx	Delivery Costs DeliveryCosts	3938000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10968000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13202000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3851000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6218000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10744000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12175000	USD
CY2020Q1	us-gaap	Acquisition Costs AcquisitionCosts	0	USD
CY2021Q1	us-gaap	Acquisition Costs AcquisitionCosts	7030000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2331000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3065000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	57438000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	75399000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11929000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3145000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22169000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	284000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3045000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1886000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	319000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1602000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2726000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13531000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24895000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13531000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24895000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.85
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26725000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29313000	shares
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1297000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-296000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12234000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25191000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	507000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7394000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	484043000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	117354000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	3593000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-296000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	744892000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4180000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1297000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	138358000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13531000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-24895000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1477000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1004000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2349000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3065000	USD
CY2020Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	24000	USD
CY2021Q1	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	219000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2321000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	879000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1073000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4125000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7248000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1905000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	141000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1008000	USD
CY2021Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	882000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22149000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7867000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	509000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1845000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	252000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	495000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6988000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	996000	USD
CY2020Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-10908000	USD
CY2021Q1	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-6749000	USD
CY2020Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-5638000	USD
CY2021Q1	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-4072000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3406000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12532000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	492000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1377000	USD
CY2020Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	28000	USD
CY2020Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	922000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1923000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	148634000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1437000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151962000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3145000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	484713000	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	42000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3139000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	484665000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-588000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	139000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2292000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	320310000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102295000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	613659000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102174000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	613548000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	121000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	111000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102295000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	613659000	USD
CY2020Q1	us-gaap	Interest Paid InterestPaid	16000	USD
CY2021Q1	us-gaap	Interest Paid InterestPaid	1120000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2020Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	190000	USD
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	190000	USD
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	117354000	USD
CY2020Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	13000	USD
CY2021Q1	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	102000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, income taxes, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets of Dosh, income tax valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates.</span></div>
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	500000	USD
CY2020Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	22300000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	203181000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	203181000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11287000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14886000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14886000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14198000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14052000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9202000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78511000	USD
CY2021Q1	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	23100000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45509000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53230000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1100000	USD
CY2021Q1	cdlx	Increase In Operating Lease Liability IncreaseInOperatingLeaseLiability	1500000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	900000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1400000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1027000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1191000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	297000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	200000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	112000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	25000	USD
CY2020Q1	cdlx	Lease Weighted Average Discount Rate Percent LeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q1	cdlx	Lease Weighted Average Discount Rate Percent LeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4230000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5263000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3164000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1807000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	611000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15075000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	740000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	14335000	USD
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000.0	USD
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	USD
CY2021Q1	us-gaap	Debt Instrument Call Feature DebtInstrumentCallFeature	26.5 million
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1100000	USD
CY2021Q1	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10000	numberOfDays
CY2021Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.98
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2021Q1	cdlx	Debt Instrument Convertible Redemption Period Days Before Maturity Date DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate	P36D
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2021Q1	cdlx	Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption	75000000.0	USD
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2021Q1	cdlx	Debt Instrument Required Compliance Period Period After Written Notice DebtInstrumentRequiredCompliancePeriodPeriodAfterWrittenNotice	P60D
CY2021Q1	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2021Q1	cdlx	Debt Instrument Convertible Redemption Requirement Amount Of Other Debt Called Due DebtInstrumentConvertibleRedemptionRequirementAmountOfOtherDebtCalledDue	35000000	USD
CY2021Q1	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2021Q1	cdlx	Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance	0.25
CY2021Q1	cdlx	Debt Instrument Convertible Covenant Noncompliance Period Of Additional Interest DebtInstrumentConvertibleCovenantNoncompliancePeriodOfAdditionalInterest	P365D
CY2021Q1	cdlx	Debt Instrument Convertible Liability Component Discount Rate DebtInstrumentConvertibleLiabilityComponentDiscountRate	0.0650
CY2020Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230000000	USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	48288000	USD
CY2020Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5172000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	176540000	USD
CY2020Q3	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	53096000	USD
CY2020Q3	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1680000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	51416000	USD
CY2020Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	575000	USD
CY2020Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2321000	USD
CY2020Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	207000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3103000	USD
CY2020Q3	cdlx	Adjustments To Additional Paid In Capital Issuance Of Capped Calls AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls	26500000	USD
CY2020Q3	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	85.14
CY2020Q3	cdlx	Option Indexed To Issuers Equity Cap Price OptionIndexedToIssuersEquityCapPrice	128.51
CY2021Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2021Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	50000000.0	USD
CY2021Q1	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1875000	shares
CY2018Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Remaining For Available For Issuance SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesRemainingForAvailableForIssuance	61247	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1222316	shares
CY2021Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Authorized Annual Percentage Increase SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesAuthorizedAnnualPercentageIncrease	0.05
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1393040	shares
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4125000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7248000	USD
CY2020Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	100000	USD
CY2021Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	100000	USD
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.91
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.11
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3734000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	482000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.42
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	41043000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	471000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.38
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	40220000	USD
CY2021Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	109.70
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	300000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	100000	USD
CY2021Q1	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	109.70
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	8383000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3785000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-1008000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-882000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	7375000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	2903000	USD
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2701000	shares
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2020Q1	cdlx	Adjusted Contribution AdjustedContribution	20379000	USD
CY2021Q1	cdlx	Adjusted Contribution AdjustedContribution	24341000	USD
CY2020Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	1008000	USD
CY2021Q1	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	882000	USD
CY2020Q1	cdlx	Delivery Costs DeliveryCosts	3406000	USD
CY2021Q1	cdlx	Delivery Costs DeliveryCosts	3938000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10968000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13202000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3851000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6218000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10744000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12175000	USD
CY2020Q1	us-gaap	Acquisition Costs AcquisitionCosts	0	USD
CY2021Q1	us-gaap	Acquisition Costs AcquisitionCosts	7030000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2331000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3065000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1602000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2726000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13531000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24895000	USD
CY2020Q1	us-gaap	Revenues Revenues	45509000	USD
CY2021Q1	us-gaap	Revenues Revenues	53230000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13865000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14118000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1100000	USD
CY2021Q1	cdlx	Increase In Operating Lease Liability IncreaseInOperatingLeaseLiability	1500000	USD

Files In Submission

Name	View Source	Status
0001666071-21-000082-index-headers.html	Edgar Link	pending
0001666071-21-000082-index.html	Edgar Link	pending
0001666071-21-000082.txt	Edgar Link	pending
0001666071-21-000082-xbrl.zip	Edgar Link	pending
cdlx-20210331.htm	Edgar Link	pending
cdlx-20210331.xsd	Edgar Link	pending
cdlx-20210331_cal.xml	Edgar Link	unprocessable
cdlx-20210331_def.xml	Edgar Link	unprocessable
cdlx-20210331_g1.jpg	Edgar Link	pending
cdlx-20210331_htm.xml	Edgar Link	completed
cdlx-20210331_lab.xml	Edgar Link	unprocessable
cdlx-20210331_pre.xml	Edgar Link	unprocessable
cdlx_form10-qx2021q1xex311.htm	Edgar Link	pending
cdlx_form10-qx2021q1xex312.htm	Edgar Link	pending
cdlx_form10-qx2021q1xex321.htm	Edgar Link	pending
cdlx_form10-qx2021xex101.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2021 Q2 Form 10-Q Financial Statement

#000166607121000082 Filed on May 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2021 Q2 Form 10-Q Financial Statement

#000166607121000082 Filed on May 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx